nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A8—nephron—kidney cancer	0.0373	0.14	CbGeAlD
Cefotaxime—SLC22A8—urine—kidney cancer	0.0299	0.112	CbGeAlD
Cefotaxime—SLC22A11—nephron tubule—kidney cancer	0.0143	0.0535	CbGeAlD
Cefotaxime—SLC22A6—nephron tubule—kidney cancer	0.0134	0.0504	CbGeAlD
Cefotaxime—SLC22A11—renal system—kidney cancer	0.013	0.0486	CbGeAlD
Cefotaxime—SLC22A7—renal system—kidney cancer	0.0127	0.0474	CbGeAlD
Cefotaxime—SLC22A11—kidney—kidney cancer	0.0125	0.047	CbGeAlD
Cefotaxime—SLC22A7—kidney—kidney cancer	0.0122	0.0458	CbGeAlD
Cefotaxime—SLC22A11—cortex of kidney—kidney cancer	0.0122	0.0457	CbGeAlD
Cefotaxime—SLC22A7—cortex of kidney—kidney cancer	0.0119	0.0447	CbGeAlD
Cefotaxime—SLC22A6—cortex of kidney—kidney cancer	0.0115	0.0431	CbGeAlD
Cefotaxime—SLC15A1—nephron tubule—kidney cancer	0.0112	0.0419	CbGeAlD
Cefotaxime—SLC15A1—renal system—kidney cancer	0.0102	0.0381	CbGeAlD
Cefotaxime—SLC15A1—kidney—kidney cancer	0.00983	0.0368	CbGeAlD
Cefotaxime—SLC22A8—nephron tubule—kidney cancer	0.00805	0.0302	CbGeAlD
Cefotaxime—SLC22A8—renal system—kidney cancer	0.00732	0.0274	CbGeAlD
Cefotaxime—SLC22A8—kidney—kidney cancer	0.00707	0.0265	CbGeAlD
Cefotaxime—SLC15A2—nephron tubule—kidney cancer	0.00699	0.0262	CbGeAlD
Cefotaxime—SLC22A8—cortex of kidney—kidney cancer	0.00689	0.0258	CbGeAlD
Cefotaxime—SLC15A2—renal system—kidney cancer	0.00636	0.0238	CbGeAlD
Cefotaxime—SLC15A2—kidney—kidney cancer	0.00615	0.023	CbGeAlD
Cefotaxime—SLC15A2—cortex of kidney—kidney cancer	0.00599	0.0224	CbGeAlD
Cefotaxime—Renal failure—Gemcitabine—kidney cancer	0.00206	0.00281	CcSEcCtD
Cefotaxime—Discomfort—Everolimus—kidney cancer	0.00206	0.00281	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.00205	0.0028	CcSEcCtD
Cefotaxime—Abdominal pain—Pazopanib—kidney cancer	0.002	0.00273	CcSEcCtD
Cefotaxime—Hypersensitivity—Temsirolimus—kidney cancer	0.00198	0.0027	CcSEcCtD
Cefotaxime—Liver injury—Doxorubicin—kidney cancer	0.00197	0.00269	CcSEcCtD
Cefotaxime—Renal impairment—Capecitabine—kidney cancer	0.00197	0.00268	CcSEcCtD
Cefotaxime—Shock—Everolimus—kidney cancer	0.00197	0.00268	CcSEcCtD
Cefotaxime—Thrombocytopenia—Vinblastine—kidney cancer	0.00196	0.00268	CcSEcCtD
Cefotaxime—Agranulocytosis—Gemcitabine—kidney cancer	0.00196	0.00267	CcSEcCtD
Cefotaxime—Dermatitis bullous—Capecitabine—kidney cancer	0.00196	0.00267	CcSEcCtD
Cefotaxime—Thrombocytopenia—Everolimus—kidney cancer	0.00196	0.00267	CcSEcCtD
Cefotaxime—Angioedema—Sorafenib—kidney cancer	0.00194	0.00265	CcSEcCtD
Cefotaxime—Leukopenia—Sorafenib—kidney cancer	0.0019	0.00259	CcSEcCtD
Cefotaxime—Pruritus—Temsirolimus—kidney cancer	0.0019	0.00259	CcSEcCtD
Cefotaxime—Shock—Erlotinib—kidney cancer	0.0019	0.00259	CcSEcCtD
Cefotaxime—Haemoglobin—Gemcitabine—kidney cancer	0.00189	0.00258	CcSEcCtD
Cefotaxime—Thrombocytopenia—Erlotinib—kidney cancer	0.00189	0.00257	CcSEcCtD
Cefotaxime—Haemorrhage—Gemcitabine—kidney cancer	0.00188	0.00257	CcSEcCtD
Cefotaxime—Angioedema—Sunitinib—kidney cancer	0.00187	0.00255	CcSEcCtD
Cefotaxime—Neutropenia—Paclitaxel—kidney cancer	0.00184	0.00251	CcSEcCtD
Cefotaxime—Diarrhoea—Temsirolimus—kidney cancer	0.00184	0.00251	CcSEcCtD
Cefotaxime—Leukopenia—Sunitinib—kidney cancer	0.00183	0.0025	CcSEcCtD
Cefotaxime—Ill-defined disorder—Dactinomycin—kidney cancer	0.0018	0.00245	CcSEcCtD
Cefotaxime—Pruritus—Pazopanib—kidney cancer	0.00179	0.00244	CcSEcCtD
Cefotaxime—Erythema multiforme—Gemcitabine—kidney cancer	0.00178	0.00243	CcSEcCtD
Cefotaxime—Convulsion—Sunitinib—kidney cancer	0.00177	0.00242	CcSEcCtD
Cefotaxime—Malaise—Dactinomycin—kidney cancer	0.00175	0.00238	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00174	0.00238	CcSEcCtD
Cefotaxime—Anaphylactic shock—Sorafenib—kidney cancer	0.00173	0.00237	CcSEcCtD
Cefotaxime—Leukopenia—Dactinomycin—kidney cancer	0.00173	0.00236	CcSEcCtD
Cefotaxime—Diarrhoea—Pazopanib—kidney cancer	0.00173	0.00236	CcSEcCtD
Cefotaxime—Renal failure—Paclitaxel—kidney cancer	0.00173	0.00236	CcSEcCtD
Cefotaxime—Pain—Vinblastine—kidney cancer	0.00171	0.00234	CcSEcCtD
Cefotaxime—Pain—Everolimus—kidney cancer	0.00171	0.00233	CcSEcCtD
Cefotaxime—Vomiting—Temsirolimus—kidney cancer	0.00171	0.00233	CcSEcCtD
Cefotaxime—Shock—Sorafenib—kidney cancer	0.00171	0.00233	CcSEcCtD
Cefotaxime—Thrombocytopenia—Sorafenib—kidney cancer	0.0017	0.00232	CcSEcCtD
Cefotaxime—Rash—Temsirolimus—kidney cancer	0.00169	0.00231	CcSEcCtD
Cefotaxime—Dermatitis—Temsirolimus—kidney cancer	0.00169	0.00231	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.00169	0.0023	CcSEcCtD
Cefotaxime—Arrhythmia—Gemcitabine—kidney cancer	0.00168	0.0023	CcSEcCtD
Cefotaxime—Headache—Temsirolimus—kidney cancer	0.00168	0.00229	CcSEcCtD
Cefotaxime—Vaginal inflammation—Doxorubicin—kidney cancer	0.00166	0.00227	CcSEcCtD
Cefotaxime—Feeling abnormal—Vinblastine—kidney cancer	0.00165	0.00225	CcSEcCtD
Cefotaxime—Pain—Erlotinib—kidney cancer	0.00165	0.00225	CcSEcCtD
Cefotaxime—Feeling abnormal—Everolimus—kidney cancer	0.00165	0.00225	CcSEcCtD
Cefotaxime—Shock—Sunitinib—kidney cancer	0.00164	0.00224	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Vinblastine—kidney cancer	0.00164	0.00224	CcSEcCtD
Cefotaxime—Thrombocytopenia—Sunitinib—kidney cancer	0.00163	0.00223	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Everolimus—kidney cancer	0.00163	0.00223	CcSEcCtD
Cefotaxime—Discomfort—Dactinomycin—kidney cancer	0.00163	0.00222	CcSEcCtD
Cefotaxime—Vomiting—Pazopanib—kidney cancer	0.00161	0.00219	CcSEcCtD
Cefotaxime—Colitis—Doxorubicin—kidney cancer	0.0016	0.00218	CcSEcCtD
Cefotaxime—Rash—Pazopanib—kidney cancer	0.00159	0.00218	CcSEcCtD
Cefotaxime—Nausea—Temsirolimus—kidney cancer	0.00159	0.00218	CcSEcCtD
Cefotaxime—Dermatitis—Pazopanib—kidney cancer	0.00159	0.00217	CcSEcCtD
Cefotaxime—Bronchospasm—Capecitabine—kidney cancer	0.00159	0.00217	CcSEcCtD
Cefotaxime—Candida infection—Doxorubicin—kidney cancer	0.00159	0.00216	CcSEcCtD
Cefotaxime—Haemoglobin—Paclitaxel—kidney cancer	0.00159	0.00216	CcSEcCtD
Cefotaxime—Abdominal pain—Vinblastine—kidney cancer	0.00159	0.00216	CcSEcCtD
Cefotaxime—Headache—Pazopanib—kidney cancer	0.00158	0.00216	CcSEcCtD
Cefotaxime—Abdominal pain—Everolimus—kidney cancer	0.00158	0.00215	CcSEcCtD
Cefotaxime—Body temperature increased—Everolimus—kidney cancer	0.00158	0.00215	CcSEcCtD
Cefotaxime—Haemorrhage—Paclitaxel—kidney cancer	0.00158	0.00215	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Erlotinib—kidney cancer	0.00158	0.00215	CcSEcCtD
Cefotaxime—Vaginal infection—Doxorubicin—kidney cancer	0.00157	0.00214	CcSEcCtD
Cefotaxime—Aplastic anaemia—Doxorubicin—kidney cancer	0.00156	0.00213	CcSEcCtD
Cefotaxime—Leukopenia—Vincristine—kidney cancer	0.00155	0.00211	CcSEcCtD
Cefotaxime—Thrombocytopenia—Dactinomycin—kidney cancer	0.00155	0.00211	CcSEcCtD
Cefotaxime—Body temperature increased—Erlotinib—kidney cancer	0.00152	0.00208	CcSEcCtD
Cefotaxime—Abdominal pain—Erlotinib—kidney cancer	0.00152	0.00208	CcSEcCtD
Cefotaxime—Ill-defined disorder—Gemcitabine—kidney cancer	0.00152	0.00208	CcSEcCtD
Cefotaxime—Neutropenia—Capecitabine—kidney cancer	0.00151	0.00206	CcSEcCtD
Cefotaxime—Nausea—Pazopanib—kidney cancer	0.0015	0.00205	CcSEcCtD
Cefotaxime—Convulsion—Vincristine—kidney cancer	0.0015	0.00204	CcSEcCtD
Cefotaxime—Erythema multiforme—Paclitaxel—kidney cancer	0.00149	0.00203	CcSEcCtD
Cefotaxime—Pain—Sorafenib—kidney cancer	0.00148	0.00202	CcSEcCtD
Cefotaxime—Malaise—Gemcitabine—kidney cancer	0.00148	0.00202	CcSEcCtD
Cefotaxime—Hypersensitivity—Vinblastine—kidney cancer	0.00148	0.00202	CcSEcCtD
Cefotaxime—Hypersensitivity—Everolimus—kidney cancer	0.00147	0.00201	CcSEcCtD
Cefotaxime—Leukopenia—Gemcitabine—kidney cancer	0.00147	0.002	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00143	0.00195	CcSEcCtD
Cefotaxime—Pain—Sunitinib—kidney cancer	0.00143	0.00195	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Sorafenib—kidney cancer	0.00142	0.00193	CcSEcCtD
Cefotaxime—Renal failure—Capecitabine—kidney cancer	0.00142	0.00193	CcSEcCtD
Cefotaxime—Pruritus—Everolimus—kidney cancer	0.00141	0.00193	CcSEcCtD
Cefotaxime—Anaphylactic shock—Vincristine—kidney cancer	0.00141	0.00192	CcSEcCtD
Cefotaxime—Arrhythmia—Paclitaxel—kidney cancer	0.00141	0.00192	CcSEcCtD
Cefotaxime—Jaundice—Capecitabine—kidney cancer	0.00141	0.00192	CcSEcCtD
Cefotaxime—Thrombocytopenia—Vincristine—kidney cancer	0.00138	0.00188	CcSEcCtD
Cefotaxime—Hepatic function abnormal—Doxorubicin—kidney cancer	0.00138	0.00188	CcSEcCtD
Cefotaxime—Discomfort—Gemcitabine—kidney cancer	0.00138	0.00188	CcSEcCtD
Cefotaxime—Urticaria—Sorafenib—kidney cancer	0.00138	0.00188	CcSEcCtD
Cefotaxime—Diarrhoea—Vinblastine—kidney cancer	0.00137	0.00187	CcSEcCtD
Cefotaxime—Abdominal pain—Sorafenib—kidney cancer	0.00137	0.00187	CcSEcCtD
Cefotaxime—Body temperature increased—Sorafenib—kidney cancer	0.00137	0.00187	CcSEcCtD
Cefotaxime—Diarrhoea—Everolimus—kidney cancer	0.00137	0.00186	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Sunitinib—kidney cancer	0.00136	0.00186	CcSEcCtD
Cefotaxime—Pruritus—Erlotinib—kidney cancer	0.00136	0.00186	CcSEcCtD
Cefotaxime—Pain—Dactinomycin—kidney cancer	0.00135	0.00184	CcSEcCtD
Cefotaxime—Agranulocytosis—Capecitabine—kidney cancer	0.00135	0.00184	CcSEcCtD
Cefotaxime—Anaphylactic shock—Gemcitabine—kidney cancer	0.00134	0.00183	CcSEcCtD
Cefotaxime—Abdominal pain—Sunitinib—kidney cancer	0.00132	0.0018	CcSEcCtD
Cefotaxime—Body temperature increased—Sunitinib—kidney cancer	0.00132	0.0018	CcSEcCtD
Cefotaxime—Diarrhoea—Erlotinib—kidney cancer	0.00132	0.0018	CcSEcCtD
Cefotaxime—Thrombocytopenia—Gemcitabine—kidney cancer	0.00131	0.00179	CcSEcCtD
Cefotaxime—Feeling abnormal—Dactinomycin—kidney cancer	0.0013	0.00178	CcSEcCtD
Cefotaxime—Haemoglobin—Capecitabine—kidney cancer	0.0013	0.00177	CcSEcCtD
Cefotaxime—Hepatitis—Capecitabine—kidney cancer	0.00129	0.00177	CcSEcCtD
Cefotaxime—Haemorrhage—Capecitabine—kidney cancer	0.00129	0.00177	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00129	0.00176	CcSEcCtD
Cefotaxime—Hypersensitivity—Sorafenib—kidney cancer	0.00128	0.00174	CcSEcCtD
Cefotaxime—Vomiting—Vinblastine—kidney cancer	0.00127	0.00174	CcSEcCtD
Cefotaxime—Ill-defined disorder—Paclitaxel—kidney cancer	0.00127	0.00174	CcSEcCtD
Cefotaxime—Vomiting—Everolimus—kidney cancer	0.00127	0.00173	CcSEcCtD
Cefotaxime—Renal impairment—Doxorubicin—kidney cancer	0.00127	0.00173	CcSEcCtD
Cefotaxime—Dermatitis bullous—Doxorubicin—kidney cancer	0.00126	0.00172	CcSEcCtD
Cefotaxime—Rash—Everolimus—kidney cancer	0.00126	0.00172	CcSEcCtD
Cefotaxime—Dermatitis—Everolimus—kidney cancer	0.00126	0.00172	CcSEcCtD
Cefotaxime—Headache—Vinblastine—kidney cancer	0.00126	0.00171	CcSEcCtD
Cefotaxime—Angioedema—Paclitaxel—kidney cancer	0.00125	0.00171	CcSEcCtD
Cefotaxime—Headache—Everolimus—kidney cancer	0.00125	0.00171	CcSEcCtD
Cefotaxime—Body temperature increased—Dactinomycin—kidney cancer	0.00125	0.0017	CcSEcCtD
Cefotaxime—Abdominal pain—Dactinomycin—kidney cancer	0.00125	0.0017	CcSEcCtD
Cefotaxime—Malaise—Paclitaxel—kidney cancer	0.00124	0.00169	CcSEcCtD
Cefotaxime—Leukopenia—Paclitaxel—kidney cancer	0.00123	0.00168	CcSEcCtD
Cefotaxime—Hypersensitivity—Sunitinib—kidney cancer	0.00123	0.00168	CcSEcCtD
Cefotaxime—Pruritus—Sorafenib—kidney cancer	0.00123	0.00167	CcSEcCtD
Cefotaxime—Vomiting—Erlotinib—kidney cancer	0.00123	0.00167	CcSEcCtD
Cefotaxime—Erythema multiforme—Capecitabine—kidney cancer	0.00122	0.00167	CcSEcCtD
Cefotaxime—Rash—Erlotinib—kidney cancer	0.00122	0.00166	CcSEcCtD
Cefotaxime—Dermatitis—Erlotinib—kidney cancer	0.00121	0.00166	CcSEcCtD
Cefotaxime—Headache—Erlotinib—kidney cancer	0.00121	0.00165	CcSEcCtD
Cefotaxime—Pain—Vincristine—kidney cancer	0.00121	0.00165	CcSEcCtD
Cefotaxime—Nausea—Vinblastine—kidney cancer	0.00119	0.00162	CcSEcCtD
Cefotaxime—Convulsion—Paclitaxel—kidney cancer	0.00119	0.00162	CcSEcCtD
Cefotaxime—Nausea—Everolimus—kidney cancer	0.00119	0.00162	CcSEcCtD
Cefotaxime—Diarrhoea—Sorafenib—kidney cancer	0.00119	0.00162	CcSEcCtD
Cefotaxime—Pruritus—Sunitinib—kidney cancer	0.00118	0.00161	CcSEcCtD
Cefotaxime—Hypersensitivity—Dactinomycin—kidney cancer	0.00116	0.00159	CcSEcCtD
Cefotaxime—Arrhythmia—Capecitabine—kidney cancer	0.00116	0.00158	CcSEcCtD
Cefotaxime—Discomfort—Paclitaxel—kidney cancer	0.00116	0.00158	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Vincristine—kidney cancer	0.00115	0.00157	CcSEcCtD
Cefotaxime—Pain—Gemcitabine—kidney cancer	0.00114	0.00156	CcSEcCtD
Cefotaxime—Nausea—Erlotinib—kidney cancer	0.00114	0.00156	CcSEcCtD
Cefotaxime—Diarrhoea—Sunitinib—kidney cancer	0.00114	0.00156	CcSEcCtD
Cefotaxime—Anaphylactic shock—Paclitaxel—kidney cancer	0.00112	0.00153	CcSEcCtD
Cefotaxime—Body temperature increased—Vincristine—kidney cancer	0.00112	0.00152	CcSEcCtD
Cefotaxime—Abdominal pain—Vincristine—kidney cancer	0.00112	0.00152	CcSEcCtD
Cefotaxime—Feeling abnormal—Gemcitabine—kidney cancer	0.0011	0.0015	CcSEcCtD
Cefotaxime—Shock—Paclitaxel—kidney cancer	0.0011	0.0015	CcSEcCtD
Cefotaxime—Vomiting—Sorafenib—kidney cancer	0.0011	0.0015	CcSEcCtD
Cefotaxime—Thrombocytopenia—Paclitaxel—kidney cancer	0.0011	0.0015	CcSEcCtD
Cefotaxime—Rash—Sorafenib—kidney cancer	0.00109	0.00149	CcSEcCtD
Cefotaxime—Dermatitis—Sorafenib—kidney cancer	0.00109	0.00149	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00109	0.00148	CcSEcCtD
Cefotaxime—Headache—Sorafenib—kidney cancer	0.00109	0.00148	CcSEcCtD
Cefotaxime—Diarrhoea—Dactinomycin—kidney cancer	0.00108	0.00147	CcSEcCtD
Cefotaxime—Vomiting—Sunitinib—kidney cancer	0.00106	0.00145	CcSEcCtD
Cefotaxime—Body temperature increased—Gemcitabine—kidney cancer	0.00106	0.00144	CcSEcCtD
Cefotaxime—Rash—Sunitinib—kidney cancer	0.00105	0.00143	CcSEcCtD
Cefotaxime—Dermatitis—Sunitinib—kidney cancer	0.00105	0.00143	CcSEcCtD
Cefotaxime—Ill-defined disorder—Capecitabine—kidney cancer	0.00105	0.00143	CcSEcCtD
Cefotaxime—Headache—Sunitinib—kidney cancer	0.00105	0.00143	CcSEcCtD
Cefotaxime—Hypersensitivity—Vincristine—kidney cancer	0.00104	0.00142	CcSEcCtD
Cefotaxime—Eosinophilia—Doxorubicin—kidney cancer	0.00103	0.00141	CcSEcCtD
Cefotaxime—Nausea—Sorafenib—kidney cancer	0.00103	0.0014	CcSEcCtD
Cefotaxime—Malaise—Capecitabine—kidney cancer	0.00102	0.00139	CcSEcCtD
Cefotaxime—Leukopenia—Capecitabine—kidney cancer	0.00101	0.00138	CcSEcCtD
Cefotaxime—Vomiting—Dactinomycin—kidney cancer	0.001	0.00137	CcSEcCtD
Cefotaxime—Rash—Dactinomycin—kidney cancer	0.000996	0.00136	CcSEcCtD
Cefotaxime—Nausea—Sunitinib—kidney cancer	0.000991	0.00135	CcSEcCtD
Cefotaxime—Neutropenia—Doxorubicin—kidney cancer	0.000975	0.00133	CcSEcCtD
Cefotaxime—Diarrhoea—Vincristine—kidney cancer	0.000965	0.00132	CcSEcCtD
Cefotaxime—Pain—Paclitaxel—kidney cancer	0.000958	0.00131	CcSEcCtD
Cefotaxime—Discomfort—Capecitabine—kidney cancer	0.000948	0.00129	CcSEcCtD
Cefotaxime—Pruritus—Gemcitabine—kidney cancer	0.000947	0.00129	CcSEcCtD
Cefotaxime—Nausea—Dactinomycin—kidney cancer	0.000938	0.00128	CcSEcCtD
Cefotaxime—Feeling abnormal—Paclitaxel—kidney cancer	0.000924	0.00126	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000922	0.00126	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000916	0.00125	CcSEcCtD
Cefotaxime—Diarrhoea—Gemcitabine—kidney cancer	0.000916	0.00125	CcSEcCtD
Cefotaxime—Renal failure—Doxorubicin—kidney cancer	0.000914	0.00125	CcSEcCtD
Cefotaxime—Jaundice—Doxorubicin—kidney cancer	0.000906	0.00124	CcSEcCtD
Cefotaxime—Shock—Capecitabine—kidney cancer	0.000905	0.00123	CcSEcCtD
Cefotaxime—Thrombocytopenia—Capecitabine—kidney cancer	0.000901	0.00123	CcSEcCtD
Cefotaxime—Vomiting—Vincristine—kidney cancer	0.000897	0.00122	CcSEcCtD
Cefotaxime—Urticaria—Paclitaxel—kidney cancer	0.00089	0.00121	CcSEcCtD
Cefotaxime—Rash—Vincristine—kidney cancer	0.00089	0.00121	CcSEcCtD
Cefotaxime—Dermatitis—Vincristine—kidney cancer	0.000889	0.00121	CcSEcCtD
Cefotaxime—Abdominal pain—Paclitaxel—kidney cancer	0.000886	0.00121	CcSEcCtD
Cefotaxime—Body temperature increased—Paclitaxel—kidney cancer	0.000886	0.00121	CcSEcCtD
Cefotaxime—Headache—Vincristine—kidney cancer	0.000884	0.00121	CcSEcCtD
Cefotaxime—Agranulocytosis—Doxorubicin—kidney cancer	0.000867	0.00118	CcSEcCtD
Cefotaxime—Vomiting—Gemcitabine—kidney cancer	0.000851	0.00116	CcSEcCtD
Cefotaxime—Rash—Gemcitabine—kidney cancer	0.000844	0.00115	CcSEcCtD
Cefotaxime—Dermatitis—Gemcitabine—kidney cancer	0.000843	0.00115	CcSEcCtD
Cefotaxime—Haemoglobin—Doxorubicin—kidney cancer	0.000839	0.00114	CcSEcCtD
Cefotaxime—Headache—Gemcitabine—kidney cancer	0.000839	0.00114	CcSEcCtD
Cefotaxime—Nausea—Vincristine—kidney cancer	0.000838	0.00114	CcSEcCtD
Cefotaxime—Hepatitis—Doxorubicin—kidney cancer	0.000834	0.00114	CcSEcCtD
Cefotaxime—Haemorrhage—Doxorubicin—kidney cancer	0.000834	0.00114	CcSEcCtD
Cefotaxime—Hypersensitivity—Paclitaxel—kidney cancer	0.000826	0.00113	CcSEcCtD
Cefotaxime—Nausea—Gemcitabine—kidney cancer	0.000795	0.00108	CcSEcCtD
Cefotaxime—Pruritus—Paclitaxel—kidney cancer	0.000793	0.00108	CcSEcCtD
Cefotaxime—Erythema multiforme—Doxorubicin—kidney cancer	0.000789	0.00108	CcSEcCtD
Cefotaxime—Pain—Capecitabine—kidney cancer	0.000787	0.00107	CcSEcCtD
Cefotaxime—Diarrhoea—Paclitaxel—kidney cancer	0.000767	0.00105	CcSEcCtD
Cefotaxime—Feeling abnormal—Capecitabine—kidney cancer	0.000758	0.00103	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Capecitabine—kidney cancer	0.000752	0.00103	CcSEcCtD
Cefotaxime—Arrhythmia—Doxorubicin—kidney cancer	0.000745	0.00102	CcSEcCtD
Cefotaxime—Urticaria—Capecitabine—kidney cancer	0.000731	0.000997	CcSEcCtD
Cefotaxime—Abdominal pain—Capecitabine—kidney cancer	0.000727	0.000992	CcSEcCtD
Cefotaxime—Body temperature increased—Capecitabine—kidney cancer	0.000727	0.000992	CcSEcCtD
Cefotaxime—Vomiting—Paclitaxel—kidney cancer	0.000713	0.000972	CcSEcCtD
Cefotaxime—Rash—Paclitaxel—kidney cancer	0.000707	0.000964	CcSEcCtD
Cefotaxime—Dermatitis—Paclitaxel—kidney cancer	0.000706	0.000963	CcSEcCtD
Cefotaxime—Headache—Paclitaxel—kidney cancer	0.000702	0.000958	CcSEcCtD
Cefotaxime—Hypersensitivity—Capecitabine—kidney cancer	0.000678	0.000924	CcSEcCtD
Cefotaxime—Ill-defined disorder—Doxorubicin—kidney cancer	0.000674	0.000919	CcSEcCtD
Cefotaxime—Nausea—Paclitaxel—kidney cancer	0.000666	0.000908	CcSEcCtD
Cefotaxime—Malaise—Doxorubicin—kidney cancer	0.000655	0.000894	CcSEcCtD
Cefotaxime—Pruritus—Capecitabine—kidney cancer	0.000651	0.000888	CcSEcCtD
Cefotaxime—Leukopenia—Doxorubicin—kidney cancer	0.00065	0.000887	CcSEcCtD
Cefotaxime—Convulsion—Doxorubicin—kidney cancer	0.000629	0.000859	CcSEcCtD
Cefotaxime—Diarrhoea—Capecitabine—kidney cancer	0.000629	0.000858	CcSEcCtD
Cefotaxime—Discomfort—Doxorubicin—kidney cancer	0.000611	0.000834	CcSEcCtD
Cefotaxime—Anaphylactic shock—Doxorubicin—kidney cancer	0.000593	0.000809	CcSEcCtD
Cefotaxime—Vomiting—Capecitabine—kidney cancer	0.000585	0.000798	CcSEcCtD
Cefotaxime—Shock—Doxorubicin—kidney cancer	0.000583	0.000796	CcSEcCtD
Cefotaxime—Thrombocytopenia—Doxorubicin—kidney cancer	0.00058	0.000792	CcSEcCtD
Cefotaxime—Rash—Capecitabine—kidney cancer	0.00058	0.000791	CcSEcCtD
Cefotaxime—Dermatitis—Capecitabine—kidney cancer	0.000579	0.00079	CcSEcCtD
Cefotaxime—Headache—Capecitabine—kidney cancer	0.000576	0.000786	CcSEcCtD
Cefotaxime—Nausea—Capecitabine—kidney cancer	0.000546	0.000745	CcSEcCtD
Cefotaxime—Pain—Doxorubicin—kidney cancer	0.000507	0.000692	CcSEcCtD
Cefotaxime—Feeling abnormal—Doxorubicin—kidney cancer	0.000489	0.000666	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000485	0.000661	CcSEcCtD
Cefotaxime—Urticaria—Doxorubicin—kidney cancer	0.000471	0.000642	CcSEcCtD
Cefotaxime—Abdominal pain—Doxorubicin—kidney cancer	0.000469	0.000639	CcSEcCtD
Cefotaxime—Body temperature increased—Doxorubicin—kidney cancer	0.000469	0.000639	CcSEcCtD
Cefotaxime—Hypersensitivity—Doxorubicin—kidney cancer	0.000437	0.000596	CcSEcCtD
Cefotaxime—Pruritus—Doxorubicin—kidney cancer	0.000419	0.000572	CcSEcCtD
Cefotaxime—Diarrhoea—Doxorubicin—kidney cancer	0.000406	0.000553	CcSEcCtD
Cefotaxime—Vomiting—Doxorubicin—kidney cancer	0.000377	0.000514	CcSEcCtD
Cefotaxime—Rash—Doxorubicin—kidney cancer	0.000374	0.00051	CcSEcCtD
Cefotaxime—Dermatitis—Doxorubicin—kidney cancer	0.000373	0.000509	CcSEcCtD
Cefotaxime—Headache—Doxorubicin—kidney cancer	0.000371	0.000507	CcSEcCtD
Cefotaxime—Nausea—Doxorubicin—kidney cancer	0.000352	0.00048	CcSEcCtD
